Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,859 | 176 | 98.9% |
| Education | $32.27 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $355.03 | 14 | $0 (2019) |
| GlaxoSmithKline, LLC. | $310.50 | 26 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $275.26 | 18 | $0 (2019) |
| Allergan Inc. | $250.82 | 15 | $0 (2019) |
| Novo Nordisk Inc | $198.78 | 10 | $0 (2018) |
| AbbVie, Inc. | $140.72 | 7 | $0 (2018) |
| Amgen Inc. | $132.30 | 8 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $127.30 | 9 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $90.08 | 8 | $0 (2019) |
| Gemini Laboratories, LLC | $82.42 | 4 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $479.96 | 26 | Janssen Pharmaceuticals, Inc ($186.19) |
| 2018 | $953.64 | 63 | GlaxoSmithKline, LLC. ($151.67) |
| 2017 | $1,458 | 88 | Allergan Inc. ($180.62) |
All Payment Transactions
177 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/27/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/07/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/25/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/27/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/29/2019 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/28/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/16/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/18/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $32.67 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/16/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $10.54 | General |
| Category: Central Nervous System (CNS) | ||||||
| 04/10/2019 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL9 | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: VACCINE | ||||||
| 04/09/2019 | ARBOR PHARMACEUTICALS, INC. | Edarbi (Drug) | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/02/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.48 | General |
| Category: Cardiovascular | ||||||
| 03/22/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/07/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Virology & Specialty Care | ||||||
| 02/20/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: Central Nervous System (CNS) | ||||||
| 02/14/2019 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: VACCINES | ||||||
| 02/13/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/08/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/06/2019 | SANOFI PASTEUR INC. | ADACEL (Drug), FLUZONE HIGH-DOSE | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: VACCINES | ||||||
| 01/29/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $8.71 | General |
| Category: Central Nervous System (CNS) | ||||||
| 01/24/2019 | ARBOR PHARMACEUTICALS, INC. | Edarbi (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/22/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/19/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $35.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/17/2019 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Bone Health | ||||||
| 01/15/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,692 | 2,211 | $465,049 | $149,699 |
| 2022 | 17 | 1,750 | 2,241 | $431,960 | $139,714 |
| 2021 | 15 | 1,588 | 2,077 | $405,878 | $129,937 |
| 2020 | 16 | 1,301 | 1,562 | $279,978 | $85,949 |
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 287 | 450 | $145,350 | $44,396 | 30.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 291 | 291 | $108,543 | $39,771 | 36.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 292 | 495 | $108,405 | $32,792 | 30.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 21 | 21 | $8,337 | $5,921 | 71.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 52 | 59 | $10,325 | $4,691 | 45.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 26 | 26 | $14,612 | $4,558 | 31.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 279 | 410 | $8,200 | $3,444 | 42.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 17 | 17 | $7,684 | $2,982 | 38.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 30 | 30 | $3,300 | $2,158 | 65.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 14 | $6,076 | $1,985 | 32.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 153 | 158 | $22,120 | $1,795 | 8.1% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 13 | 13 | $2,449 | $1,700 | 69.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 35 | 35 | $1,995 | $1,126 | 56.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 32 | 32 | $1,824 | $1,027 | 56.3% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 134 | 143 | $13,585 | $687.57 | 5.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 17 | $2,244 | $665.04 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 263 | 393 | $126,939 | $39,878 | 31.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 284 | 284 | $105,932 | $39,704 | 37.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 271 | 441 | $96,579 | $29,480 | 30.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 70 | 77 | $13,475 | $6,002 | 44.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 28 | 28 | $12,656 | $5,031 | 39.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 46 | 46 | $5,060 | $3,153 | 62.3% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 11 | 11 | $3,773 | $2,734 | 72.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 14 | 14 | $7,868 | $2,513 | 31.9% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 17 | 17 | $3,145 | $2,249 | 71.5% |
About Dr. Martha Millar, MD
Dr. Martha Millar, MD is a Internal Medicine healthcare provider based in Glenview, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063591808.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Martha Millar, MD has received a total of $2,892 in payments from pharmaceutical and medical device companies, with $479.96 received in 2019. These payments were reported across 177 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($2,859).
As a Medicare-enrolled provider, Millar has provided services to 6,331 Medicare beneficiaries, totaling 8,091 services with total Medicare billing of $505,299. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Glenview, IL
- Active Since 11/03/2006
- Last Updated 03/23/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1063591808
Products in Payments
- XARELTO (Drug) $294.23
- Victoza (Drug) $146.65
- SYMBICORT (Drug) $141.18
- ANORO (Drug) $127.26
- FARXIGA (Drug) $120.10
- Trintellix (Drug) $113.40
- Prolia (Biological) $111.30
- LINZESS (Drug) $110.29
- XIFAXAN (Drug) $85.04
- Unithroid (Drug) $82.42
- BREO (Drug) $77.54
- NUEDEXTA (Drug) $65.28
- INVOKANA (Drug) $60.80
- TUDORZA PRESSAIR (Drug) $54.57
- BYVALSON (Drug) $54.34
- Synthroid (Drug) $46.62
- SHINGRIX (Biological) $46.61
- JANUVIA (Drug) $46.55
- Vascepa (Drug) $44.65
- FLUZONE HIGH-DOSE (Drug) $44.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Glenview
Jose Nazari, Md, MD
Internal Medicine — Payments: $25,736
Dr. Thomas Ficho, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $20,710
Dr. Videsha Kulkarni, Md, MD
Internal Medicine — Payments: $14,537
Sheree Lipkis, Md, MD
Internal Medicine — Payments: $13,193
Evan Lipkis, Md, MD
Internal Medicine — Payments: $10,604
Dr. Najam Saqib, M.d, M.D
Internal Medicine — Payments: $9,427